11:06 AM EDT, 05/21/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending modestly higher late Tuesday morning, rising 0.32% to 1,431.33 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by semiconductor company Sequans Communications ( SQNS ) and telecommunications operator Telefonica ( TEF ) , which rose 4.4% and 2.7, respectively. They were followed by biopharmaceutical company DBV Technologies ( DBVT ) and medical device maker EDAP TMS ( EDAP ) , which increased 1.6% and 1.4%, respectively.

The decliners from continental Europe were led by biotech firm Evaxion Biotech ( EVAX ) and biopharmaceutical company Cellectis ( CLLS ) , which fell 5.2% and 4.3%, respectively. They were followed by biopharmaceutical company Calliditas Therapeutics ( CALT ) and kidney dialysis company Fresenius Medical Care ( FMS ) , which were down 2.4% and 2%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) , which soared 113%, followed by pharmaceutical company Silence Therapeutics ( SLN ) , which rose 3.2%. They were followed by biopharmaceutical company NuCana ( NCNA ) and pharmaceutical company AstraZeneca ( AZN ) , which were up 2.5%, each.

The decliners from the UK and Ireland were led by biotech firm Trinity Biotech ( TRIB ) and software firm Endava ( DAVA ) , which dropped 2.6% and 1.9%, respectively. They were followed by telecommunications operator Vodafone Group ( VOD ) and biotech firm Autolus Therapeutics ( AUTL ) , which lost 1.8% and 1.6%, respectively.